Watch Ticker

Abeona Therapeutics Inc. Common Stock

Go to Abeona Therapeutics Inc. Common Stock Website

$6.47

0.00 (0.00%)

Live

Previous Close

$6.47

Day Range

$0 - $0

Previous Day Range

$6.32 - $6.52

Market Cap

$328.4 million USD

Day Vol.

Previous Day Vol.

448362

Currency

USD

Primary Exchange

Nasdaq

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Kuick Research - US FDA Orphan Drug Rare Disease Market Clinical Trials Drug Sales Insight 2030

The report provides detailed insights into the US orphan drug market, highlighting the significant growth opportunity of over $190 billion by 2030. It covers over 1,400 FDA-designated orphan drugs, including their clinical trials, pricing, dosage, and sales data.

Related tickers: ABEO.

Read Full Article

Abeona Therapeutics Inc. - U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

The U.S. FDA has approved ZEVASKYN, the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB), a serious and debilitating genetic skin disease. ZEVASKYN has demonstrated clinically meaningful wound healing and pain reduction with a single surgical application.

Related tickers: ABEO.

Read Full Article

Trending Tickers

Please sign in to view